Literature DB >> 19373617

A reproductive subtype of depression: conceptualizing models and moving toward etiology.

Jennifer L Payne1, Jennifer Teitelbaum Palmer, Hadine Joffe.   

Abstract

The lifetime risk for major depression in women is well known to be twice the risk in men and is especially high during the reproductive years between menarche and menopause. A subset of reproductive-age women experience depressive episodes that are triggered by hormonal fluctuations. Such "reproductive depressions" involve episodes of depression that occur specifically during the premenstrual, postpartum, and perimenopausal phases in women. These reproductive subtypes of depression can be conceptualized as a specific biological response to the effects of hormonal fluctuations in the brain. The different types of reproductive depressions are associated with each other, have unique risk factors that are distinct from nonreproductive depression episodes, and respond to both hormonal and nonhormonal interventions. This review uses a PubMed search of relevant literature to discuss clinical, animal, and genetic evidence for reproductive depression as a specific subtype of major depression. Unique treatment options, such as hormonal interventions, are also discussed, and hypotheses regarding the underlying biology of reproductive depression-including interactions between the serotonergic system and estrogen, as well as specific effects on neurosteroids-are explored. This review will provide evidence supporting reproductive depression as a distinct clinical entity with specific treatment approaches and a unique biology that is separate from nonreproductive depression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373617      PMCID: PMC3741092          DOI: 10.1080/10673220902899706

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  125 in total

1.  Advances in the translational neuroscience of neurosteroids.

Authors:  C Neill Epperson; Harriet deWit; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

2.  Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression.

Authors:  K S Kendler; L M Karkowski; L A Corey; M C Neale
Journal:  Am J Psychiatry       Date:  1998-09       Impact factor: 18.112

3.  Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes.

Authors:  L D Griffin; S H Mellon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 4.  The association between premenstrual dysphoric disorder and other mood disorders.

Authors:  K A Yonkers
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

5.  Fluoxetine efficacy in menopausal women with and without estrogen replacement.

Authors:  J Amsterdam; F Garcia-España; J Fawcett; F Quitkin; F Reimherr; J Rosenbaum; C Beasley
Journal:  J Affect Disord       Date:  1999-09       Impact factor: 4.839

Review 6.  Endocrine aspects of postnatal mental disorders.

Authors:  A Wieck
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1989-12

Review 7.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

8.  Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial.

Authors:  Mary F Morrison; Michael J Kallan; Thomas Ten Have; Ira Katz; Kathryn Tweedy; Michelle Battistini
Journal:  Biol Psychiatry       Date:  2004-02-15       Impact factor: 13.382

9.  Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression.

Authors:  Elizabeth A Young; Susan G Kornstein; Anne T Harvey; Stephen R Wisniewski; Jennifer Barkin; Maurizio Fava; Madhukar H Trivedi; A John Rush
Journal:  Psychoneuroendocrinology       Date:  2007-07-16       Impact factor: 4.905

10.  Medical history in women with premenstrual syndrome.

Authors:  C J Chuong; D M Burgos
Journal:  J Psychosom Obstet Gynaecol       Date:  1995-03       Impact factor: 2.949

View more
  41 in total

1.  Progesterone receptor antagonist CDB-4124 increases depression-like behavior in mice without affecting locomotor ability.

Authors:  Ethan H Beckley; Angela C Scibelli; Deborah A Finn
Journal:  Psychoneuroendocrinology       Date:  2010-12-15       Impact factor: 4.905

2.  Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels.

Authors:  Lauren Osborne; Makena Clive; Mary Kimmel; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Jennifer Judy; Samantha Meilman; Aviva Braier; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Fernando Goes; Jennifer L Payne; Elisabeth B Binder; Zachary Kaminsky
Journal:  Neuropsychopharmacology       Date:  2015-10-27       Impact factor: 7.853

Review 3.  Reproductive Affective Disorders: a Review of the Genetic Evidence for Premenstrual Dysphoric Disorder and Postpartum Depression.

Authors:  Katherine McEvoy; Lauren M Osborne; Julie Nanavati; Jennifer L Payne
Journal:  Curr Psychiatry Rep       Date:  2017-10-30       Impact factor: 5.285

4.  Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women's Health.

Authors:  L Wilson; N Pandeya; J Byles; G Mishra
Journal:  Epidemiol Psychiatr Sci       Date:  2017-02-13       Impact factor: 6.892

5.  What midlife women want from gynecologists: a survey of patients in specialty and private practices.

Authors:  Beth A Prairie; Marcia Klein-Patel; MinJae Lee; Katherine L Wisner; Judith L Balk
Journal:  J Womens Health (Larchmt)       Date:  2014-01-09       Impact factor: 2.681

Review 6.  Neuroendocrine Effects of Lactation and Hormone-Gene-Environment Interactions.

Authors:  Kirsten Gust; Christina Caccese; Amanda Larosa; Tuong-Vi Nguyen
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

Review 7.  Recognizing and Managing Postpartum Psychosis: A Clinical Guide for Obstetric Providers.

Authors:  Lauren M Osborne
Journal:  Obstet Gynecol Clin North Am       Date:  2018-09       Impact factor: 2.844

Review 8.  Psychiatric consultation to the postpartum mother.

Authors:  Eleanor A Anderson; Deborah R Kim
Journal:  Curr Psychiatry Rep       Date:  2015-04       Impact factor: 5.285

9.  GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study.

Authors:  Kristina M Deligiannidis; Elif M Sikoglu; Scott A Shaffer; Blaise Frederick; Abby E Svenson; Andre Kopoyan; Chelsea A Kosma; Anthony J Rothschild; Constance M Moore
Journal:  J Psychiatr Res       Date:  2013-03-15       Impact factor: 4.791

10.  Prenatal beta-endorphin as an early predictor of postpartum depressive symptoms in euthymic women.

Authors:  Ilona S Yim; Laura M Glynn; Christine Dunkel Schetter; Calvin J Hobel; Aleksandra Chicz-Demet; Curt A Sandman
Journal:  J Affect Disord       Date:  2010-01-03       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.